0.1406
price up icon4.23%   0.0057
after-market Handel nachbörslich: .14 -0.0006 -0.43%
loading

Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
0.23%
5.153
5.141 3.824 6.783 3.82
Gross Profit
3.47%
2.953
3.059 2.988 3.937 2.11
Operating Expenses
19.60%
7.778
9.674 9.37 8.671 6.975
Interest Income/Expense
0.00%
1.10
1.10 0.80 0.50 -
Depreciation and Amortization
12.33%
0.51
0.454 0.442 0.384 0.306
Operating Income/Loss
27.06%
-4.825
-6.615 -6.382 -4.734 -4.865
Income/Loss From Continuing Operations Before Tax
28.74%
-5.523
-7.751 -6.954 -5.40 -5.013
Net Income/Loss
28.74%
-5.523
-7.751 -6.894 -5.40 -5.013
Attributable To Noncontrolling Interest
39.13%
-0.042
-0.069 - - -
Basic Average Shares
20.83%
17.68
14.63 - 10.96 9.0872
Diluted Average Shares
20.83%
17.68
14.63 - 10.96 9.0872
Basic Earnings Per Share
40.38%
-0.31
-0.52 - -0.49 -0.55
Diluted Earnings Per Share
40.38%
-0.31
-0.52 - -0.49 -0.55
$2.4201
price down icon 7.98%
$0.1208
price up icon 0.67%
$0.265
price up icon 1.81%
NXL NXL
$2.14
price down icon 9.32%
$2.19
price up icon 2.58%
$5.31
price up icon 2.91%
Kapitalisierung:     |  Volumen (24h):